Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted

This article was originally published in The Pink Sheet Daily

Executive Summary

Rep. Farr says Congressional Budget Office scoring problems could not be overcome, meaning FY 2013 FDA user fees lost to sequester may not be recovered, but amendment will be proposed to ensure FY 2014 fees are not lost in the upcoming appropriations bill.

Advertisement

Related Content

FDA Strains Under New NDA Review Model; Will Industry Want To Retain It?
FDA Mandates Need Accompanying Resources, Hamburg Says
Hamburg, Like Industry, Wants Predictability – But In FDA Funding
Generic User Fees Need Small Business Waiver, Firms Say; Congress May Agree
FDA User Fees Could Be Freed From Sequester As Senate Drafts Bill
FDA Budget May Need To Be Trimmed 5% In FY 2015
OxyContin’s Abuse-Deterrent Claims Strong, But Stronger Claims Possible
FDA’s Budget Proposal: It’s The User Fees’ Agency Now
PDUFA Communications Hurt By Sequestration As Late-Stage Meetings Begin
DTC User Fees Rejected By House Approps Panel As FDA Safety Funds Get Boost

Topics

Advertisement
UsernamePublicRestriction

Register

PS075917

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel